Company intelligence / Profile preview

Presight Ventures

West Hollywood, California, United States

Ownership: Private
Development stage: Other

Overview

Presight Capital is a venture capital firm and the flagship fund of Apeiron Investment Group. It manages over $600 million across two early-stage funds, investing from seed to IPO stages with check sizes ranging from $500K to $20M+. The portfolio includes significant investments in biotech and healthcare companies such as ATAI Life Sciences, AbCellera, Compass Pathways, and Alto Neuroscience.

Industry: Investors

Beyond the preview

Go deeper on Presight Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presight Ventures.

Explore the full profile